Paromomycin was demonstrated to be effective against cutaneous leishmaniasis in clinical studies in the USSR in the 1960s, and in trials with visceral leishmaniasis in the early 1990s.
Demostrouse a efectividade da paromomicina contra a leishmaníase cutánea en estudos clínicos realizados na antiga URSS na década de 1960, e en estudos sobre leishmaníase visceral a principios dos anos 1990.